I'm LongbridgeAI, I can summarize articles.New insider activity at TRex Bio, Inc. ( (TRXB) ) has taken place on October 13, 2026.
Significant shareholder SVLSF VI, LLC has increased its stake in TRex Bio, Inc., purchasing 92,857 shares of the company’s stock in a recent transaction. The deal, valued at $1,299,998, underscores a notable capital commitment and may signal growing confidence in TRex Bio’s future prospects from one of its key investors.
TRex Bio’s shares have seen modest first-day trading, hovering just above their $14 IPO price, after opening indications between about $13.90 and $14.50 as investors gauged demand for the new biotech listing. The IPO was priced at the low end of its range amid cautious market conditions, while the company simultaneously implemented a new charter and bylaws to support a flexible capital structure and more standardized public‑company governance, which may factor into analysts’ evolving valuation frameworks.
More about TRex Bio, Inc.
YTD Price Performance: 0.21%
Average Trading Volume: 723,771
Current Market Cap: $385.1M
